| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ce8c8f0c7cab044e35235b55c3abda23 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-922
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2330-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2015-8518
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-734 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56966
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0641
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0644 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-078 |
| filingDate |
2017-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e1124def375b28d55eaa15cef737157
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_414119654b39a6630ef8d3c4f5a029e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dab1d8afadccd957980284d634b9bf67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b9edb1aa3fd940f4d2b37bd04246c3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2c3c6dedc17c3336b4e986ba614c0bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a58ac1adc10523c6b1ec6ef75c436379 |
| publicationDate |
2019-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2017293931-A1 |
| titleOfInvention |
Compositions and methods related to therapeutic cell systems expressing exogenous RNA |
| abstract |
The invention includes compositions and methods related to erythroid cells comprising exogenous RNA encoding a protein. The exogenous RNA can comprise a heterologous untranslated region comprising a regulatory element. Alternatively or in combination, the exogenous RNA can comprise chemical modifications. |
| priorityDate |
2016-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |